PulseCath B.V. devel­ops, man­u­fac­tures and mar­kets min­i­mal inva­sive cir­cu­la­to­ry sup­port sys­tems which are safe, effec­tive, and very cost effec­tive.

Pulsecath’s iVAC 3L™ is a mid-range left ven­tricukar assist device that gen­er­ates a blood­flow of up to 3L/min. The lead prod­uct, the iVAC 2L™, gen­er­ates approx­y­mate­ly 2.5 L/min and can be insert­ed through the femoral artery.

Portfolio: MedSciences Seed Fund B.V. and MedSciences Capital II B.V.

Current prod­uct devel­op­ment stage: CE mark and mar­ket intro­duc­tion.